BGNE Message Board Post 9928714 | BeiGene Ltd.
home / stock / bgne / bgne message board
sophial
(investorshub)
Posted on: Feb/27/2018 23:28:18
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138887881
BeiGene Announces Approval of REVLIMID for Newly Diagnosed
News, Short Squeeze, Breakout and More Instantly...
-
Arm D of SEQUOIA study evaluated treatment-naïve patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma with del(17p) and/or TP53 mutation Preliminary data suggest promising efficacy and tolerability Safety profile was consistent with results o...
-
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with BeiGene’s goals to expand its presence and directly manage operations in the MENA region. T...
-
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 with a fireside chat at 1:20 pm EDT. Live webcast of this event can be acce...